调控性细胞因子调节与COVID-19存活率相关的早期同型特异反应
Sebastián Castro-Trujillo1, Juanita Castro-Meneses1,2, María Clemencia Rojas3
1División de Inmunología, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva, Huila, Colombia.
Frontiers in immunology
|May 9, 2025
概括
严重的COVID-19结局与无效的抗体反应和延迟的班级切换有关,特别是在非幸存者中. 早期调节性细胞因子模式与幸存者的保护性抗体发育相关,有助于风险识别.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 病理生理学 病理生理学
背景情况:
- 在严重的COVID-19中确定有效抗体反应的免疫标志物对于疫情准备至关重要.
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 感染涉及失调的血栓炎症和细胞因子风暴,影响抗体同型反应和临床结果.
研究的目的:
- 调查COVID-19死亡率与核蛋白 (N),尖峰 (S) 和受体结合域 (RBD) 特定的IgM,IgA和IgG抗体的动态,大小和性之间的关联.
- 评估病毒特异性抗体反应,细胞因子模式和血栓炎症标志物在幸存者与非幸存者的关系.
主要方法:
- 住院COVID-19患者 (幸存者n=62,非幸存者n=17) 和对照队伍的多中心研究.
- 开发间接与酶相关的免疫吸收试验 (ELISA) 来评估病毒特异性IgM,IgA和IgG同型.
- 评估促炎性 (IL-6,TNF-α) 和调节性 (IL-10,TGF-β1,sTNFRI) 细胞因子水平.
主要成果:
- 与幸存者相比,非幸存者显示N特异性IgM/IgA增加,但与幸存者相比,IgG-S和IgG-RBD的类切换延迟.
- 幸存者表现出与血栓炎症成比例的抗体反应,而非幸存者表现出由于不受控制的炎症导致的解离.
- 在幸存者早期感染 (<10天) 的主导调节性细胞因子模式与保护性IgG-S和IgG-RBD抗体有很强的相关性.
结论:
- 不幸存者表现出无效的N介导抗体反应,未能控制炎症,并显示已损害的类切换到S/RBD特定的IgG.
- 调节性细胞因子轴,包括TGF-β1,可能是COVID-19中有效的抗体介导免疫的关键相关因子.
- 已开发的免疫检测可以帮助监测患者并识别有风险的人群,特别是在资源有限的环境中.
关键词:
在 COVID-19 疫情中,在 IgA A 里面.在IgG IgG的基础上.的IgM IgM 的情况.在RBD中,RBD是RBD.这就是SARS-CoV-2病毒.在TGF-β1中.斯派克斯派克斯派克斯就是一个尖刺.更多相关视频
相关概念视频
Immune Response Against Viral Pathogens
478
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
478
Inflammatory Response
1.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.6K
T Cell Types and Functions
627
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
627
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


